Evidence map›Paper›PMID 35495520›Full record

ArticleRSC advances2021

Hybrid compound based on diethylenetriaminecopper(ii) cations and scarce V-monosubstituted β-octamolybdate as water oxidation catalyst.

Halyna I Buvailo, Valeriya G Makhankova, Vladimir N Kokozay, Iryna V Omelchenko, Svitlana V Shishkina, Alina Bieńko, Mariia V Pavliuk, Sergii I Shylin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Halyna I BuvailoDepartment of Chemistry, Taras Shevchenko National University of Kyiv Volodymyrska Street 64/13 01601 Kyiv Ukraine.ORCID https://orcid.org/0000-0003-3356-688X
Valeriya G MakhankovaInstitute of High Technologies, Taras Shevchenko National University of Kyiv Hlushkova Avenue, 4g 03022 Kyiv Ukraine leram@univ.kiev.ua.ORCID https://orcid.org/0000-0002-0012-5108
Vladimir N KokozayDepartment of Chemistry, Taras Shevchenko National University of Kyiv Volodymyrska Street 64/13 01601 Kyiv Ukraine.
Iryna V OmelchenkoInstitute for Single Crystals, National Academy of Sciences of Ukraine Nauky Ave 60 61001 Kharkiv Ukraine.ORCID https://orcid.org/0000-0002-6882-6832
Svitlana V ShishkinaInstitute for Single Crystals, National Academy of Sciences of Ukraine Nauky Ave 60 61001 Kharkiv Ukraine.ORCID https://orcid.org/0000-0002-3946-1061
Alina BieńkoFaculty of Chemistry, University of Wroclaw F. Joliot-Curie 14 50-383 Wroclaw Poland.ORCID https://orcid.org/0000-0002-2714-3197
Mariia V PavliukDepartment of Chemistry - Ångström Laboratory, Uppsala University P. O. Box 523 75120 Uppsala Sweden sergii.shylin@kemi.uu.se.
Sergii I ShylinDepartment of Chemistry - Ångström Laboratory, Uppsala University P. O. Box 523 75120 Uppsala Sweden sergii.shylin@kemi.uu.se.ORCID https://orcid.org/0000-0003-2104-1912
Taras Shevchenko National University of Kyiv · UANational Academy of Sciences of Ukraine · UAUppsala University · SEUniversity of Wrocław · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herein, we report on a new hybrid compound (NH

Identifiers

PMID35495520
PMCPMC9041742
OpenAlexW3203490128

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.